Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren Lasko, Kenneth D. Bromberg, Bailin Shaw et al.|Nature|2017Cited by 853
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancerEmily J. Faivre, Yu Shen, Keith F. McDaniel et al.|Nature|2020Cited by 404
Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of CancerThorsten Oost, Stephen W. Fesik, Chaohong Sun et al.|Journal of Medicinal Chemistry|2004Cited by 364
Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and SelectivityMilan Bruncko, Andrew J. Souers, Le Wang et al.|Journal of Medicinal Chemistry|2015Cited by 152
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complexQi Hao, Michael E. Kort, Manoj K Rathinaswamy et al.|Communications Chemistry|2024Cited by 9